Mayne Pharma | MYX - Des Atouts

Prix De L'Action
2.20
Variation Quotidienne
0.07 3.29%
Mensuellement
-15.71%
Annuel
-69.57%
Q1 Prévisions
2.33




Des Atouts Changement Date
Ansell USD 3.33B 3.2M 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Healius AUD 3.07B 84.2M 2024-12
Integral Diagnostics AUD 744.28M 1.52M 2024-06
Medical Developments International AUD 63.57M 2.83M 2025-12
Nanosonics AUD 279.25M 6.77M 2025-12
Polynovo AUD 123.37M 4.04M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Sigma Healthcare AUD 8.29B 6.91B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12